Qiagen (QIA) Stock Forecast & Price Target

11 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QIA Analyst Ratings

Moderate Buy

7 Buy

6 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QIA Stock 12 Month Forecast

Average Price Target

€35.74

▲(1.10% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is €35.74 with a high forecast of €42.97 and a low forecast of €31.57. The average price target represents a 1.10% change from the last price of €35.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"€28","45":"€45","32.25":"€32.3","36.5":"€36.5","40.75":"€40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":42.96564657,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€42.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.7404031468,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€35.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.56659748,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€31.57</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,32.25,36.5,40.75,45],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.9,34.597357428461535,35.29471485692307,35.992072285384616,36.68942971384615,37.38678714230769,38.084144570769226,38.78150199923077,39.478859427692306,40.17621685615384,40.87357428461538,41.570931713076924,42.26828914153846,{"y":42.96564657,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.9,34.041569472830766,34.18313894566154,34.32470841849231,34.466277891323074,34.60784736415385,34.749416836984615,34.89098630981538,35.03255578264615,35.17412525547692,35.31569472830769,35.45726420113846,35.59883367396923,{"y":35.7404031468,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,33.9,33.72050749846154,33.541014996923074,33.36152249538461,33.18202999384615,33.00253749230769,32.823044990769226,32.64355248923077,32.46405998769231,32.28456748615385,32.105074984615385,31.925582483076923,31.74608998153846,{"y":31.56659748,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":41.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.825,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.642,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.24,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.812,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.037,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.905,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.065,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.295,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.9,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.035,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.815,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.9,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€42.97

Average Price Target€35.74

Lowest Price Target€31.57

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Kepler Capital

Not Ranked

Kepler Capital

€33.85

Hold

-4.25%

Downside

Initiated

06/25/26

Qiagen (QGEN) Gets a Hold from Kepler Capital

Luke Sergott

Barclays

€33.32

Hold

-5.74%

Downside

Reiterated

06/24/26

Barclays Sticks to Their Hold Rating for Qiagen (QGEN)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

06/23/26

DZ BANK AG Remains a Buy on Qiagen (QGEN)

Aisyah Noor

Morgan Stanley

€35.07→€36.83

Buy

4.18%

Upside

Upgraded

06/23/26

Positive Report for Qiagen (QGEN) from Morgan Stanley

Jan Koch

Deutsche Bank

―

Buy

―

Reiterated

06/17/26

Analysts Offer Insights on Healthcare Companies: Humacyte (NASDAQ: HUMA) and Qiagen (NYSE: QGEN)

Daniel Arias

Stifel Nicolaus

€31.57

Hold

-10.70%

Downside

Reiterated

06/16/26

Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Qiagen (NYSE: QGEN) and Edwards Lifesciences (NYSE: EW)

Michael Ryskin

Bank of America Securities

€42.97

Buy

21.54%

Upside

Reiterated

05/13/26

Analysts Conflicted on These Healthcare Names: Qiagen (NYSE: QGEN), SAB Biotherapeutics (NASDAQ: SABS) and Moderna (NASDAQ: MRNA)

Daniel Brennan

TD Cowen

€40.34→€35.07

Hold

-0.78%

Downside

Assigned

05/07/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

05/07/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Catherine Ramsey Schulte

Robert W. Baird

€46.47→€37.7

Buy

6.66%

Upside

Upgraded

04/29/26

Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird

Patrick B Donnelly

Citi

€48.23→€33.32

Hold

-5.74%

Downside

Reiterated

04/29/26

Qiagen price target lowered to $38 from $55 at CitiQiagen price target lowered to $38 from $55 at Citi

Casey Woodring

J.P. Morgan

€52.61→€39.46

Buy

11.62%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

€33.32

Hold

-5.74%

Downside

Reiterated

04/28/26

Qiagen Kept at Hold as Guidance Cut and QuantiFERON Weakness Offset H2 Rebound Hopes and Heighten Execution Risk

Harry Gillis

Berenberg Bank

€46→€50

Buy

41.44%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)

Dan Leonard

RBC Capital

€45.6

Hold

28.98%

Upside

Reiterated

02/09/26

Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Kepler Capital

Not Ranked

Kepler Capital

€33.85

Hold

-4.25%

Downside

Initiated

06/25/26

Qiagen (QGEN) Gets a Hold from Kepler Capital

Luke Sergott

Barclays

€33.32

Hold

-5.74%

Downside

Reiterated

06/24/26

Barclays Sticks to Their Hold Rating for Qiagen (QGEN)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

06/23/26

DZ BANK AG Remains a Buy on Qiagen (QGEN)

Aisyah Noor

Morgan Stanley

€35.07→€36.83

Buy

4.18%

Upside

Upgraded

06/23/26

Positive Report for Qiagen (QGEN) from Morgan Stanley

Jan Koch

Deutsche Bank

―

Buy

―

Reiterated

06/17/26

Analysts Offer Insights on Healthcare Companies: Humacyte (NASDAQ: HUMA) and Qiagen (NYSE: QGEN)

Daniel Arias

Stifel Nicolaus

€31.57

Hold

-10.70%

Downside

Reiterated

06/16/26

Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Qiagen (NYSE: QGEN) and Edwards Lifesciences (NYSE: EW)

Michael Ryskin

Bank of America Securities

€42.97

Buy

21.54%

Upside

Reiterated

05/13/26

Analysts Conflicted on These Healthcare Names: Qiagen (NYSE: QGEN), SAB Biotherapeutics (NASDAQ: SABS) and Moderna (NASDAQ: MRNA)

Daniel Brennan

TD Cowen

€40.34→€35.07

Hold

-0.78%

Downside

Assigned

05/07/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

05/07/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Catherine Ramsey Schulte

Robert W. Baird

€46.47→€37.7

Buy

6.66%

Upside

Upgraded

04/29/26

Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird

Patrick B Donnelly

Citi

€48.23→€33.32

Hold

-5.74%

Downside

Reiterated

04/29/26

Qiagen price target lowered to $38 from $55 at CitiQiagen price target lowered to $38 from $55 at Citi

Casey Woodring

J.P. Morgan

€52.61→€39.46

Buy

11.62%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

€33.32

Hold

-5.74%

Downside

Reiterated

04/28/26

Qiagen Kept at Hold as Guidance Cut and QuantiFERON Weakness Offset H2 Rebound Hopes and Heighten Execution Risk

Harry Gillis

Berenberg Bank

€46→€50

Buy

41.44%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)

Dan Leonard

RBC Capital

€45.6

Hold

28.98%

Upside

Reiterated

02/09/26

Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

3 Months

Jan KochDeutsche Bank

Success Rate

6/9 ratings generated profit

Average Return

+6.00%

Copying Jan Koch's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +6.00% per trade.

1 Year

Jan KochDeutsche Bank

Success Rate

8/9 ratings generated profit

Average Return

+14.09%

Copying Jan Koch's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +14.09% per trade.

2 Years

Jan KochDeutsche Bank

Success Rate

8/9 ratings generated profit

Average Return

+14.09%

Copying Jan Koch's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +14.09% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QIA Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QIA has received 7 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. QIA average Analyst price target in the past 3 months is 35.74.

Each month's total comprises the sum of three months' worth of ratings.

QIA Financial Forecast

QIA Earnings Forecast

Next quarter’s earnings estimate for QIA is €0.53 with a range of €0.52 to €0.54. The previous quarter’s EPS was €0.47. QIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QIA has Performed in-line its overall industry.

QIA Sales Forecast

Next quarter’s sales forecast for QIA is €466.19M with a range of €461.87M to €484.99M. The previous quarter’s sales results were €431.69M. QIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QIA has Performed in-line its overall industry.

QIA Stock Forecast FAQ

What is DE:QIA’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen’s 12-month average price target is 35.74.

What is DE:QIA’s upside potential, based on the analysts’ average price target?

Qiagen has 1.10% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Qiagen a Buy, Sell or Hold?

Qiagen has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 6 hold ratings and 0 sell ratings.

What is Qiagen’s share price target?

The average share price target for Qiagen is 35.74. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €42.97 ,and the lowest forecast is €31.57. The average share price target represents 1.10% Increase from the current price of €35.35.

What do analysts say about Qiagen?

Qiagen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Qiagen?

To buy shares of DE:QIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Qiagen (QIA) Stock Forecast & Price Target

QIA Analyst Ratings

QIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

QIA Analyst Recommendation Trends

QIA Financial Forecast

QIA Earnings Forecast

QIA Sales Forecast

QIA Stock Forecast FAQ

Detailed List of Analyst Forecasts